BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home » Blogs » BioWorld MedTech Perspectives » O Canada Eh!

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology / Imaging

O Canada Eh!

Nov. 17, 2011
By Amanda Pedersen

Canadian flag

As most of the U.S. population prepares for the rapidly-approaching Thanksgiving holiday, I will be visiting our neighbor to the north, feasting my eyes on all that Ontario has to offer in the way of advanced medical devices. Medical Device Daily has been invited by the Ontario Ministry of Economic Development and Innovation (MEDI) to participate in a medical device media tour of the Canadian province.

Throughout my visit, I plan to post frequent blogs here about my experience on the tour and what I learn about Ontario’s medical device industry. I also plan to tweet about the tour so be sure to follow us on Twitter at MedDevicesDaily to find out how the tour is going.

The tour is scheduled to begin with a stop at the Ontario Investment and Trade Centre in Toronto for an overview of Ontario’s advanced medical devices industry presented by John Soloninka, president/CEO of the Health Technology Exchange (HTX). HTX supports emerging and established Ontario-based companies to develop, produce and commercialize innovative advanced health technologies. That stop also includes a presentation from Tom Corr, president/CEO of the Ontario Centres of Excellence (OCE). OCE aims to foster training and development of the next generation of innovators and entrepreneurs through its partnerships with industry, universities, research hospitals, investors and governments.

The tour also is expected to include stops at the GE Global Digital Pathology Centre of Excellence, The Hospital for Sick Children Centre for Image-Guided Innovation & Therapeutic Intervention, Hologic, Tornado Medical Systems, and Baylis Medical Company, all in Toronto. A visit to Thunder Bay will include stops at the Thunder Bay Regional Research Institute, RegenMed, and Warnex Pro-DNA Services.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 13, 2026.
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • NRF2 activators reported in Vailima Peninsula patent

    BioWorld Science
    Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing